Cargando…

Diagnostic Approach for Venous Thromboembolism in Cancer Patients

SIMPLE SUMMARY: Cancer patients have an increased risk of venous thromboembolic diseases, which are a major cause of morbidity and mortality in this population. The current recommended diagnostic approach consists of a systematic algorithm based on clinical probability, D-dimer measurement, and/or d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helfer, Hélène, Skaff, Yara, Happe, Florent, Djennaoui, Sadji, Chidiac, Jean, Poénou, Géraldine, Righini, Marc, Mahé, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252026/ https://www.ncbi.nlm.nih.gov/pubmed/37296993 http://dx.doi.org/10.3390/cancers15113031

Ejemplares similares

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients
por: Poénou, Géraldine, et al.
Publicado: (2022)

Granulosa tumor: two spontaneous pregnancies after combined medico-surgical treatment: case report and review of the literature
por: Kaakoua, Mohamed, et al.
Publicado: (2023)

Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
por: Heestermans, Marco, et al.
Publicado: (2022)

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022)

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
por: Poenou, Géraldine, et al.
Publicado: (2023)

Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued
por: Mayenga, Marie, et al.
Publicado: (2023)

Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
por: Plaisance, Ludovic, et al.
Publicado: (2021)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
por: Gerotziafas, Grigoris T, et al.
Publicado: (2014)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists
por: Bosquet, Antoine, et al.
Publicado: (2022)

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
por: Mahé, Isabelle, et al.
Publicado: (2020)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Venous Thromboembolism – Current Diagnostic and Treatment Modalities
por: Bosevski, Marijan, et al.
Publicado: (2016)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2022)

D‐dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta‐analysis
por: Bellesini, Marta, et al.
Publicado: (2021)

Screening for cancer in unprovoked venous thromboembolism
por: Shivji, Salma, et al.
Publicado: (2019)

The Adherence to Initial Processes of Care in Elderly Patients with Acute Venous Thromboembolism
por: Stuck, Anna K., et al.
Publicado: (2014)

Assessing the risk of recurrent venous thromboembolism – a practical approach
por: Fahrni, Jennifer, et al.
Publicado: (2015)

Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism
por: Keita, Ingre, et al.
Publicado: (2017)

Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study
por: Mahé, Isabelle, et al.
Publicado: (2021)

Patient Characteristics and Preferences Regarding Anticoagulant Treatment in Venous Thromboembolic Disease
por: Lanéelle, Damien, et al.
Publicado: (2021)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Screening for Occult Cancer in Patients with Venous Thromboembolism
por: D’Astous, Julien, et al.
Publicado: (2020)

Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France
por: Bertoletti, Laurent, et al.
Publicado: (2023)

Venous thromboembolism deserves your attention
por: Marc Samama, Charles
Publicado: (2001)

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients
por: Hohl Moinat, Christine, et al.
Publicado: (2014)

Venous thromboembolism and cancer risk
por: Sandén, Per, et al.
Publicado: (2016)

Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020)

How we changed our approach to venous thromboembolism
por: Ageno, Walter
Publicado: (2022)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Venous thromboembolism and pregnancy
por: D’Uva, Maristella, et al.
Publicado: (2010)

The epidemiology of venous thromboembolism
por: Heit, John A., et al.
Publicado: (2016)

Neonatal Venous Thromboembolism
por: Haley, Kristina M.
Publicado: (2017)

Venous thromboembolism and infection
por: Maasdorp, S D
Publicado: (2021)

Venous anomalies and thromboembolism
por: Dix, Caroline, et al.
Publicado: (2023)

Venous thromboembolism in women
por: Peclat, Ana Paula Rolim Maia, et al.
Publicado: (2023)

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk
por: Morimont, Laure, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8rf8q4mgi4l448gp558s53a4u3